Ineffectiveness of corona remediation: World Health Organization

News Desk: The World Health Organization (WHO) has canceled the drug 'RemDCV' for the treatment of Covid-19. Based on a review of several tests, the drug could not cure patients, the agency said.

Corona epidemic treatment has elicited worldwide response to the effectiveness of RMDCV. Even US President Donald Trump himself insisted on the use of this drug.

In the meantime, Hu said, this medicine has no effectiveness. The WHO also advised not to use remedicv for the treatment of covid-19.

A team of experts from the World Health Organization (WHO) said in a BMG report that "no results have been found in the end. There is no sign of recovery even after application on the patients. '

They also said that patients cannot be given ‘remedicv’ for treatment of corona. This is because there is no evidence that the use of this drug has reduced coronary mortality or reduced the need for ventilation in patients.

Remedicv treatment of corona is quite effective. This is what the biotechnology company Gilead claimed after the initial trial. The whole world responded to RAMDCV. However, the use of this drug was controversial from the beginning.

RemedicV is one of the two antiviral drugs around the world to get treatment for Covid. But after testing, the WHO objected to its effectiveness.

The World Health Organization has reached this conclusion after conducting a study on 11,026 patients from more than 30 countries.

Biotechnology company Gilead has raised questions about Hu's statement. In a statement, they countered, "We are disappointed with Hu's decision. This is because the number of corona around the world was increasing at a rapid rate, when doctors were relying on this drug. Now they are questioning the effectiveness of this drug.

Earlier, the US Food and Drug Administration approved the use of RMDCV on an emergency basis in the treatment of the anti-viral drug Covid-19 of the US Gilliard Science Company.